Neurofibromatosis, Inc.

Medical Advisory Board

David H. Gutmann, MD, PhD
Donald O. Schnuck Family Professor of Neurology, Pediatrics

Areas of interest include inherited cancer syndromes of the nervous system, Neurofibromatosis 1 (NF1), familial cancer syndromes that affect the brain, spinal cord, and nerves.

St. Louis Children’s Hospital
One Children’s Place, Second Floor, Suite D
St. Louis, MO 63110
Phone: 314.454.6120
Fax: 314.454.2523


Laura Klesse, M.D., Ph.D
Assistant Professor of Pediatrics, Pediatric Oncology, University of Texas SouthwesternMedical Center Dallas, Director NF Clinic

Children’s Medical Center
1935 Medical District Dr.
Dallas, TX 75235
Phone: 214.456.2382
Fax: 214.528.2050


Maciej M. Mrugala, MD, Phd, MPH
Assistant Professor of Neurology and Neurological Surgery, Division of Neuro-Oncology
University of Washington School of Medicine
Affiliate Investigator, Fred Hutchinson Cancer Research Center

Dr. Mrugala treats primary glial brain tumors, primary central nervous system lymphoma, and Neurofibromatosis. His research interests are in experimental
therapeutics, and complications of treatments in neurooncology.

Seattle Cancer Care Alliance
825 Eastlake Ave. E. P.O. Box 1902
Seattle, WA 98109
Phone: 206.598.9487


James H. Tonsgard, MD
Associate Professor of Pediatrics and Neurology
Director, University of Chicago Ambulatory
Program for Neurofibromatosis

A pediatric neurologist, Dr. James Tonsgard is an expert in epilepsy and seizures, Neurofibromatosis, and tuberous sclerosis. He also specializes in mental retardation and metabolic brain disease.  Dr. Tonsgard is an active researcher and is studying various biochemical processes that may affect neurological diseases. He is also interested in research related to Neurofibromatosis.

University of Chicago Hospitals
5841 S. Maryland Ave., MC 3055
Chicago, IL 60637
Phone: 773.702.6488


Yuan Zhu, Ph.D.
Assistant Professor of Internal Medicine
Assistant Professor of Cell and Developmental Biology

Dr. Zhu is interested in using mouse genetics to study the molecular and cellular mechanisms underlying initiation and progression of tumors in the both central nervous system (CNS) and peripheral nervous system (PNS). He is exploring these mouse models to address: (1) whether neural stem/progenitor cells or differentiated cells are the cellular targets for tumors of the nervous system, (2) how the tumor suppressor genes regulate growth and transformation of neural stem/progenitor cells in vivo and in vitro, and (3) whether there are stem cell-like cells or cancer stem cells in astrocytomas and peripheral nerve sheath tumors.

University of Michigan Medical School
109 Zina Pitcher Place
2053 BSRB, Box 2200
Ann Arbor, MI 48109
Phone: 734.647.3033

 


Copyright © 2012 Neurofibromatosis, Inc.